Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,245.00
+10.00 (0.24%)
Last updated: Nov 25, 2025, 12:52 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 88.37 billion as of November 26, 2025. Its market cap has decreased by -21.09% in one year.
Market Cap
88.37B
Enterprise Value
100.74B
Revenue
173.80B
Ranking
n/a
PE Ratio
12.38
Stock Price
4,245.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 88.37B, an increase of 198.14%. That is a compound annual growth rate of 5.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 86.34B | -16.21% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | 176.87B | 118.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Peptron | 8.60T |
| Yuhan | 8.60T |
| LigaChem Biosciences | 6.25T |